Una de las mayores metas de Life4me+ — prevenir nuevos casos de VIH y otras ITS, hepatitis C y tuberculosis.

El app ayuda a establecer una comunicación anónima entre médicos y personas vih+. Te permite organizar tu horario de toma de tratamiento de manera conveniente y fijar recordatorios personalizados que se pueden ocultar.

Todas las noticias

Archivo

✕

26 octubre 2016

6129

HIVR4P 2016: Circumcision offers major contribution to ending HIV epidemic as a public health threat

HIVR4P 2016: Circumcision offers major contribution to ending HIV epidemic as a public health threat

Kenya’s medical circumcision program launched early with ambition, charting circumcisions performed for 1.3 million men by the end of 2015, leaving evaluators asking what is and what will be the impact of this HIV prevention intervention on the epidemic? Through the lens ...

26 octubre 2016

4821

Dolutegravir and central nervous system side-effects: abacavir, older age increase the risk

Dolutegravir and central nervous system side-effects: abacavir, older age increase the risk

Insomnia, dizziness, headache and other central nervous system side-effects are occurring more frequently with everyday use of dolutegravir than clinical trials had suggested, and are most likely to occur in women, people over 60 and people starting abacavir at the same ...

26 octubre 2016

4315

A Cas9 Ribonucleoprotein Platform for Functional Genetic Studies of HIV-Host Interactions in Primary Human T Cells

A Cas9 Ribonucleoprotein Platform for Functional Genetic Studies of HIV-Host Interactions in Primary Human T Cells

New genetic tools are needed to understand the functional interactions between HIV and human host factors in primary cells said Sell Reports. A group of american scientists developed a method to edit the genome of primary CD4+ T cells by electroporation of CRISPR/Cas9 ribonucleoproteins ...

25 octubre 2016

3902

Accelerated oral nanomedicine discovery from miniaturized screening to clinical production exemplified by paediatric HIV nanotherapies

Accelerated oral nanomedicine discovery from miniaturized screening to clinical production exemplified by paediatric HIV nanotherapies

Considerable scope exists to vary the physical and chemical properties of nanoparticles, with subsequent impact on biological interactions; however, no accelerated process to access large nanoparticle material space is currently available, hampering the development of new ...

24 octubre 2016

4431

Lack of epidemiologic indicators increases risk of missed HIV diagnosis

Lack of epidemiologic indicators increases risk of missed HIV diagnosis

Patients who do not have epidemiologic indicators of HIV are more likely to have a history of missed presentation, are less likely to get tested for HIV, and are more likely to neglect HIV symptoms, according to results of a cross-sectional study published in PLoS One

24 octubre 2016

4566

Two thirds of oral prep-using MSM would switch to long-term shots

Two thirds of oral prep-using MSM would switch to long-term shots

One third of men who have sex with men (MSM) using daily oral PrEP for a year or more would “definitely switch” to a long-acting PrEP shot every 3 months, while another third would “probably switch,” according to results of a 90-man survey. Hispanic and nonwhite men were ...

24 octubre 2016

4478

New Hep C panviral not better than earlier drugs?

New Hep C panviral not better than earlier drugs?

German researchers looking for proof of the effectiveness of the drug combo sofosbuvir/velpatasvir (epclusa/gilead sciences) found the studies submitted by the manufacturer proved it offered “a hint of added benefit” in only two of ten subindications. The direct-acting ...

21 octubre 2016

4694

Controlling the HIV epidemic: ambitious funding, expanded workforce, innovations and micro-focus needed

Controlling the HIV epidemic: ambitious funding, expanded workforce, innovations and micro-focus needed

Advocates who seek to end AIDS by 2030 should be ready to call on Hillary Clinton to massively increase United States support for the Global Fund to Fight AIDS and the US President’s Emergency Plan for AIDS Relief (PEPFAR) if she wins next month’s US presidential election, ...

21 octubre 2016

4752

Insurers accused of discriminating against HIV patients

Insurers accused of discriminating against HIV patients

The health law prohibits insurers from discriminating against people with serious illnesses, but some marketplace plans sidestep that taboo by making the drugs that people with HIV need unavailable or unaffordable, complaints filed recently (PDF) with the Department of Health ...

21 octubre 2016

6562

Norway to provide free HIV-preventing PrEP drugs to at-risk gay men

Norway to provide free HIV-preventing PrEP drugs to at-risk gay men

Norway is sending a bold message to the world by becoming the first country to make HIV-preventing PrEP drugs available through its National Health Service. It is a result of two years of lobbying by HIV Norway – the national organisation for people living with HIV.

1...113 114 115 116